Source: FARM PROGRESS, 4/13/16

 The Food and Drug Administration’s Center for Veterinary Medicine took the first step toward rescinding its approval for the use of carbadox to treat swine because the drug may leave trace amounts of a carcinogenic residue.

For more of this story click here.